Medical Properties Trust (MPW) director awarded 30,303 shares in new stock grant

Rhea-AI Filing Summary

Medical Properties Trust (MPW) director Daniel Paul Sparks reported an equity award of 30,303 shares of common stock on January 8, 2026. The award was recorded at a price of $0 per share, indicating it is a stock-based compensation grant rather than an open‑market purchase.

After this grant, Sparks beneficially owns 150,546 shares of Medical Properties Trust common stock in direct form. According to the footnote, these shares vest in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026, meaning the award will become fully vested over a three‑year period if service-based conditions are met.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SPARKS DANIEL PAUL

(Last) (First) (Middle)

1000 URBAN CENTER DRIVE

SUITE 501

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MEDICAL PROPERTIES TRUST INC [ MPW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/08/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.001	01/08/2026		A		30,303(1)	A	$0	150,546	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

	W. Zachary Riddle, by power of attorney	01/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did MPW director Daniel Paul Sparks report?

Director Daniel Paul Sparks reported receiving an award of 30,303 shares of Medical Properties Trust common stock on January 8, 2026, recorded at a price of $0 per share.

How many MPW shares does Daniel Paul Sparks own after this transaction?

Following the reported grant, Daniel Paul Sparks beneficially owns 150,546 shares of Medical Properties Trust common stock in direct form.

What are the vesting terms of the 30,303 MPW shares granted to Daniel Paul Sparks?

The 30,303 shares vest ratably at the beginning of each of the 12 calendar quarters starting on April 1, 2026, resulting in full vesting over three years.

Was the MPW insider transaction a purchase on the open market?

No. The reported transaction shows a grant of 30,303 shares at a price of $0 per share, which is consistent with stock-based compensation rather than an open‑market purchase.

Is Daniel Paul Sparks a director, officer, or major shareholder of Medical Properties Trust?

According to the filing, Daniel Paul Sparks is a director of Medical Properties Trust Inc. (MPW) and is not listed as an officer or 10% owner.